| Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020 | 2018 | 2020 |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016 | 1200 | 2016 |
| Hepatocyte growth factor/c‐met signaling is required for stem‐cell–mediated liver regeneration in mice T Ishikawa, VM Factor, JU Marquardt, C Raggi, D Seo, M Kitade, ... Hepatology 55 (4), 1215-1226, 2012 | 249 | 2012 |
| Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types Á Holczbauer, VM Factor, JB Andersen, JU Marquardt, DE Kleiner, ... Gastroenterology 145 (1), 221-231, 2013 | 212 | 2013 |
| Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature Reviews Gastroenterology & Hepatology 13 (5), 261-280, 2016 | 197 | 2016 |
| Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages C Raggi, M Correnti, A Sica, JB Andersen, V Cardinale, D Alvaro, ... Journal of hepatology 66 (1), 102-115, 2017 | 168 | 2017 |
| Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies C Raggi, HS Mousa, M Correnti, A Sica, P Invernizzi Oncogene 35 (6), 671-682, 2016 | 160 | 2016 |
| Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma C Nepal, CJ O'Rourke, DVNP Oliveira, A Taranta, S Shema, P Gautam, ... Hepatology 68 (3), 949-963, 2018 | 134 | 2018 |
| An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer JB Andersen, VM Factor, JU Marquardt, C Raggi, YH Lee, D Seo, ... Science translational medicine 2 (54), 54ra77-54ra77, 2010 | 129 | 2010 |
| Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma C Raggi, ML Taddei, E Sacco, N Navari, M Correnti, B Piombanti, ... Journal of Hepatology 74 (6), 1373-1385, 2021 | 114 | 2021 |
| Metabolic reprogramming in cholangiocarcinoma C Raggi, ML Taddei, C Rae, C Braconi, F Marra Journal of hepatology 77 (3), 849-864, 2022 | 104 | 2022 |
| Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity S Piaggi, C Raggi, A Corti, E Pitzalis, MC Mascherpa, M Saviozzi, ... Carcinogenesis 31 (5), 804-811, 2010 | 103 | 2010 |
| Mesenchymal stem cells, aging and regenerative medicine C Raggi, AC Berardi Muscles, ligaments and tendons journal 2 (3), 239, 2012 | 99 | 2012 |
| Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways JU Marquardt, C Raggi, JB Andersen, D Seo, I Avital, D Geller, YH Lee, ... Hepatology 54 (3), 1031-1042, 2011 | 98 | 2011 |
| Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2 YH Lee, D Seo, KJ Choi, JB Andersen, MA Won, M Kitade, ... Cancer research 74 (17), 4752-4761, 2014 | 94 | 2014 |
| Epigenetic reprogramming modulates malignant properties of human liver cancer C Raggi, VM Factor, D Seo, A Holczbauer, MC Gillen, JU Marquardt, ... Hepatology 59 (6), 2251-2262, 2014 | 91 | 2014 |
| Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts C Raggi, P Invernizzi, JB Andersen Journal of hepatology 62 (1), 198-207, 2015 | 90 | 2015 |
| The role of stroma in cholangiocarcinoma: the intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium A Gentilini, M Pastore, F Marra, C Raggi International Journal of Molecular Sciences 19 (10), 2885, 2018 | 89 | 2018 |
| Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma YH Lee, JB Andersen, HT Song, AD Judge, D Seo, T Ishikawa, ... Cancer research 70 (21), 8264-8269, 2010 | 85 | 2010 |
| Dysregulation of iron metabolism in cholangiocarcinoma stem-like cells C Raggi, E Gammella, M Correnti, P Buratti, E Forti, JB Andersen, G Alpini, ... Scientific reports 7 (1), 17667, 2017 | 81 | 2017 |
